Using the CGGA male dataset, the expression profile of A2AR was then compared to the expression of three critical immune checkpoints (PD-1, PD-L1, CTLA-4) known to be highly expressed in gliomas. This evidence concerns the gene ADORA2A and central nervous system cancer.